Literature DB >> 28254794

miR-33 Regulation of Adaptive Fibrotic Response in Cardiac Remodeling.

Xinbo Zhang1, Carlos Fernández-Hernando2.   

Abstract

Entities:  

Keywords:  Editorials; atherosclerosis; cell proliferation; extracellular matrix; fibroblasts; heart failure

Mesh：

Substances：

Year:  2017        PMID： 28254794      PMCID： PMC5375109          DOI： 10.1161/CIRCRESAHA.117.310575

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

Review 1.  Non-coding RNAs as modulators of the cardiac fibroblast phenotype.

Authors:  Maria-Teresa Piccoli; Christian Bär; Thomas Thum
Journal:  J Mol Cell Cardiol       Date:  2016-01-04       Impact factor: 5.000

2.  ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.

Authors:  Laurent Yvan-Charvet; Tamara Pagler; Emmanuel L Gautier; Serine Avagyan; Read L Siry; Seongah Han; Carrie L Welch; Nan Wang; Gwendalyn J Randolph; Hans W Snoeck; Alan R Tall
Journal:  Science       Date:  2010-05-20       Impact factor: 47.728

3.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.

Authors:  Alberto Dávalos; Leigh Goedeke; Peter Smibert; Cristina M Ramírez; Nikhil P Warrier; Ursula Andreo; Daniel Cirera-Salinas; Katey Rayner; Uthra Suresh; José Carlos Pastor-Pareja; Enric Esplugues; Edward A Fisher; Luiz O F Penalva; Kathryn J Moore; Yajaira Suárez; Eric C Lai; Carlos Fernández-Hernando
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

4.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

5.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

6.  Mir-33 regulates cell proliferation and cell cycle progression.

Authors:  Daniel Cirera-Salinas; Montse Pauta; Ryan M Allen; Alessandro G Salerno; Cristina M Ramírez; Aranzazu Chamorro-Jorganes; Amarylis C Wanschel; Miguel A Lasuncion; Manuel Morales-Ruiz; Yajaira Suarez; Ángel Baldan; Enric Esplugues; Carlos Fernández-Hernando
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

7.  Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts.

Authors:  Lisa Chilton; Wayne R Giles; Godfrey L Smith
Journal:  J Physiol       Date:  2007-06-14       Impact factor: 5.182

8.  Revisiting Cardiac Cellular Composition.

Authors:  Alexander R Pinto; Alexei Ilinykh; Malina J Ivey; Jill T Kuwabara; Michelle L D'Antoni; Ryan Debuque; Anjana Chandran; Lina Wang; Komal Arora; Nadia A Rosenthal; Michelle D Tallquist
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

9.  miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.

Authors:  Emilie Distel; Tessa J Barrett; Kellie Chung; Natasha M Girgis; Saj Parathath; Christine C Essau; Andrew J Murphy; Kathryn J Moore; Edward A Fisher
Journal:  Circ Res       Date:  2014-09-08       Impact factor: 17.367

10.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.

Authors:  Jian-Fu Chen; Elizabeth P Murchison; Ruhang Tang; Thomas E Callis; Mariko Tatsuguchi; Zhongliang Deng; Mauricio Rojas; Scott M Hammond; Michael D Schneider; Craig H Selzman; Gerhard Meissner; Cam Patterson; Gregory J Hannon; Da-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-06       Impact factor: 11.205
View more
  3 in total

1.  Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis.

Authors:  Nathan L Price; Verónica Miguel; Wen Ding; Abhishek K Singh; Shipra Malik; Noemi Rotllan; Anna Moshnikova; Jakub Toczek; Caroline Zeiss; Mehran M Sadeghi; Noemi Arias; Ángel Baldán; Oleg A Andreev; Diego Rodríguez-Puyol; Raman Bahal; Yana K Reshetnyak; Yajaira Suárez; Carlos Fernández-Hernando; Santiago Lamas
Journal:  JCI Insight       Date:  2019-11-14

2.  Differentially expressed lncRNAs, miRNAs and mRNAs with associated ceRNA networks in a mouse model of myocardial ischemia/reperfusion injury.

Authors:  Rui Zhang; Jiali Wang; Baoshan Liu; Wenjun Wang; Xinhui Fan; Boyuan Zheng; Qiuhuan Yuan; Mengyang Xue; Feng Xu; Ping Guo; Yuguo Chen
Journal:  Mol Med Rep       Date:  2020-07-06       Impact factor: 2.952

3.  The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction.

Authors:  Xudong Zhang; Shuai Yuan; Huaping Li; Jiabing Zhan; Feng Wang; Jiahui Fan; Xiang Nie; Yan Wang; Zheng Wen; Yanghui Chen; Chen Chen; Dao Wen Wang
Journal:  Signal Transduct Target Ther       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.